These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 9022015

  • 1. Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire.
    Burrows SR, Silins SL, Cross SM, Peh CA, Rischmueller M, Burrows JM, Elliott SL, McCluskey J.
    Eur J Immunol; 1997 Jan; 27(1):178-82. PubMed ID: 9022015
    [Abstract] [Full Text] [Related]

  • 2. Cross-reactive memory T cells for Epstein-Barr virus augment the alloresponse to common human leukocyte antigens: degenerate recognition of major histocompatibility complex-bound peptide by T cells and its role in alloreactivity.
    Burrows SR, Silins SL, Khanna R, Burrows JM, Rischmueller M, McCluskey J, Moss DJ.
    Eur J Immunol; 1997 Jul; 27(7):1726-36. PubMed ID: 9247584
    [Abstract] [Full Text] [Related]

  • 3. T cell receptor repertoire for a viral epitope in humans is diversified by tolerance to a background major histocompatibility complex antigen.
    Burrows SR, Silins SL, Moss DJ, Khanna R, Misko IS, Argaet VP.
    J Exp Med; 1995 Dec 01; 182(6):1703-15. PubMed ID: 7500015
    [Abstract] [Full Text] [Related]

  • 4. An alloresponse in humans is dominated by cytotoxic T lymphocytes (CTL) cross-reactive with a single Epstein-Barr virus CTL epitope: implications for graft-versus-host disease.
    Burrows SR, Khanna R, Burrows JM, Moss DJ.
    J Exp Med; 1994 Apr 01; 179(4):1155-61. PubMed ID: 7511682
    [Abstract] [Full Text] [Related]

  • 5. The shaping of T cell receptor recognition by self-tolerance.
    Gras S, Burrows SR, Kjer-Nielsen L, Clements CS, Liu YC, Sullivan LC, Bell MJ, Brooks AG, Purcell AW, McCluskey J, Rossjohn J.
    Immunity; 2009 Feb 20; 30(2):193-203. PubMed ID: 19167249
    [Abstract] [Full Text] [Related]

  • 6. A single specific amino acid residue in peptide antigens is sufficient to activate memory CTL: potential role of cross-reactive peptides in memory T cell maintenance.
    Reali E, Guerrini R, Marastoni M, Tomatis R, Masucci MG, Traniello S, Gavioli R.
    J Immunol; 1999 Jan 01; 162(1):106-13. PubMed ID: 9886375
    [Abstract] [Full Text] [Related]

  • 7. New tools to monitor the impact of viral infection on the alloreactive T-cell repertoire.
    D'Orsogna LJ, Amir AL, Zoet YM, van der Meer-Prins PM, van der Slik AR, Kester MG, Heemskerk MH, Doxiadis II, Roelen DL, Claas FH.
    Tissue Antigens; 2009 Oct 01; 74(4):290-7. PubMed ID: 19624615
    [Abstract] [Full Text] [Related]

  • 8. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.
    Silins SL, Cross SM, Krauer KG, Moss DJ, Schmidt CW, Misko IS.
    J Clin Invest; 1998 Oct 15; 102(8):1551-8. PubMed ID: 9788968
    [Abstract] [Full Text] [Related]

  • 9. Analysis of the donor-specific cytotoxic T lymphocyte repertoire in a patient with a long term surviving allograft. Frequency, specificity, and phenotype of donor-reactive T cell receptor (TCR)-alpha beta+ and TCR-gamma delta+ clones.
    Vandekerckhove BA, Datema G, Koning F, Goulmy E, Persijn GG, Van Rood JJ, Claas FH, De Vries JE.
    J Immunol; 1990 Feb 15; 144(4):1288-94. PubMed ID: 2137487
    [Abstract] [Full Text] [Related]

  • 10. Cross-recognition of a mouse H-2-peptide complex by human HLA-restricted cytotoxic T cells.
    Murray RJ, Brooks JM, Rickinson AB, Rowe M.
    Eur J Immunol; 1990 Mar 15; 20(3):659-64. PubMed ID: 1690661
    [Abstract] [Full Text] [Related]

  • 11. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V, Höllsberg P.
    J Med Virol; 2004 Apr 15; 72(4):635-45. PubMed ID: 14981767
    [Abstract] [Full Text] [Related]

  • 12. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection.
    Ely LK, Green KJ, Beddoe T, Clements CS, Miles JJ, Bottomley SP, Zernich D, Kjer-Nielsen L, Purcell AW, McCluskey J, Rossjohn J, Burrows SR.
    J Immunol; 2005 May 01; 174(9):5593-601. PubMed ID: 15843558
    [Abstract] [Full Text] [Related]

  • 13. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA B8 revealed by analysis of epitopes and eluted peptides.
    Sutton J, Rowland-Jones S, Rosenberg W, Nixon D, Gotch F, Gao XM, Murray N, Spoonas A, Driscoll P, Smith M.
    Eur J Immunol; 1993 Feb 01; 23(2):447-53. PubMed ID: 7679646
    [Abstract] [Full Text] [Related]

  • 14. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G, Rickinson AB.
    Eur J Immunol; 1987 Jul 01; 17(7):1007-13. PubMed ID: 2440688
    [Abstract] [Full Text] [Related]

  • 15. Quantitative and functional diversity of cross-reactive EBV-specific CD8+ T cells in a longitudinal study cohort of lung transplant recipients.
    Mifsud NA, Nguyen TH, Tait BD, Kotsimbos TC.
    Transplantation; 2010 Dec 27; 90(12):1439-49. PubMed ID: 21042237
    [Abstract] [Full Text] [Related]

  • 16. Assessment and characterization of the cytolytic T lymphocyte response against Epstein-Barr virus in patients with non-Hodgkin's lymphoma after autologous peripheral blood stem cell transplantation.
    Nolte A, Buhmann R, Straka C, Emmerich B, Hallek M.
    Bone Marrow Transplant; 1998 May 27; 21(9):909-16. PubMed ID: 9613783
    [Abstract] [Full Text] [Related]

  • 17. Dendritic cells engineered to express defined allo-HLA peptide complexes induce antigen-specific cytotoxic T cells efficiently killing tumour cells.
    Stronen E, Abrahamsen IW, Gaudernack G, Wälchli S, Munthe E, Buus S, Johansen FE, Lund-Johansen F, Olweus J.
    Scand J Immunol; 2009 Apr 27; 69(4):319-28. PubMed ID: 19284496
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of human EBV- and CMV-specific cytolytic effector function using allogeneic HLA molecules.
    D'Orsogna LJ, van den Heuvel H, van der Meer-Prins EM, Roelen DL, Doxiadis II, Claas FH.
    J Immunol; 2012 Nov 15; 189(10):4825-31. PubMed ID: 23077240
    [Abstract] [Full Text] [Related]

  • 19. Dengue virus-specific, HLA-B35-restricted, human CD8+ cytotoxic T lymphocyte (CTL) clones. Recognition of NS3 amino acids 500 to 508 by CTL clones of two different serotype specificities.
    Livingston PG, Kurane I, Dai LC, Okamoto Y, Lai CJ, Men R, Karaki S, Takiguchi M, Ennis FA.
    J Immunol; 1995 Feb 01; 154(3):1287-95. PubMed ID: 7529799
    [Abstract] [Full Text] [Related]

  • 20. The clonal composition of a peptide-specific oligoclonal CTL repertoire selected in response to persistent EBV infection is stable over time.
    Levitsky V, de Campos-Lima PO, Frisan T, Masucci MG.
    J Immunol; 1998 Jul 15; 161(2):594-601. PubMed ID: 9670932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.